The area of rare disorders is very problematic, because Pharmac looks at issues from a population perspective, so those rare disorders actually are difficult to deal with. I don't think that those who suffer in New Zealand are particularly generously treated.
A year ago the government instructed Pharmac to reallocate some money for rare disorders, although our understanding is that it hasn't really been spent. It was a small amount for five years, and that budget hasn't been used, but Graeme might have some other comments about that.